Logo image of OREGE.PA

OREGE (OREGE.PA) Stock Fundamental Analysis

EPA:OREGE - Euronext Paris - Matif - FR0010609206 - Common Stock - Currency: EUR

0.29  +0 (+1.05%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OREGE. OREGE was compared to 42 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of OREGE have multiple concerns. OREGE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OREGE had negative earnings in the past year.
In the past year OREGE has reported a negative cash flow from operations.
In the past 5 years OREGE always reported negative net income.
OREGE had a negative operating cash flow in each of the past 5 years.
OREGE.PA Yearly Net Income VS EBIT VS OCF VS FCFOREGE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

OREGE has a worse Return On Assets (-78.64%) than 88.10% of its industry peers.
Industry RankSector Rank
ROA -78.64%
ROE N/A
ROIC N/A
ROA(3y)-82.82%
ROA(5y)-75.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OREGE.PA Yearly ROA, ROE, ROICOREGE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

OREGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OREGE.PA Yearly Profit, Operating, Gross MarginsOREGE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

2

2. Health

2.1 Basic Checks

OREGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OREGE has about the same amount of shares outstanding.
The number of shares outstanding for OREGE remains at a similar level compared to 5 years ago.
The debt/assets ratio for OREGE is higher compared to a year ago.
OREGE.PA Yearly Shares OutstandingOREGE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OREGE.PA Yearly Total Debt VS Total AssetsOREGE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

OREGE has an Altman-Z score of -17.78. This is a bad value and indicates that OREGE is not financially healthy and even has some risk of bankruptcy.
OREGE has a worse Altman-Z score (-17.78) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -17.78
ROIC/WACCN/A
WACC2.63%
OREGE.PA Yearly LT Debt VS Equity VS FCFOREGE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

OREGE has a Current Ratio of 1.39. This is a normal value and indicates that OREGE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.39, OREGE is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
A Quick Ratio of 0.92 indicates that OREGE may have some problems paying its short term obligations.
With a Quick ratio value of 0.92, OREGE perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.92
OREGE.PA Yearly Current Assets VS Current LiabilitesOREGE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

8

3. Growth

3.1 Past

OREGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.35%, which is quite good.
Looking at the last year, OREGE shows a very strong growth in Revenue. The Revenue has grown by 141.86%.
OREGE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.64% yearly.
EPS 1Y (TTM)16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.9%
Revenue 1Y (TTM)141.86%
Revenue growth 3Y10.38%
Revenue growth 5Y26.64%
Sales Q2Q%485.38%

3.2 Future

The Earnings Per Share is expected to grow by 20.42% on average over the next years. This is a very strong growth
OREGE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 63.30% yearly.
EPS Next Y40%
EPS Next 2Y20.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2Y63.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OREGE.PA Yearly Revenue VS EstimatesOREGE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M
OREGE.PA Yearly EPS VS EstimatesOREGE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OREGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OREGE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OREGE.PA Price Earnings VS Forward Price EarningsOREGE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OREGE.PA Per share dataOREGE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as OREGE's earnings are expected to grow with 20.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OREGE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OREGE

EPA:OREGE (7/11/2025, 7:00:00 PM)

0.29

+0 (+1.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-28 2025-04-28/amc
Earnings (Next)07-29 2025-07-29
Inst Owners2.87%
Inst Owner ChangeN/A
Ins Owners1.42%
Ins Owner ChangeN/A
Market Cap14.67M
Analysts40
Price Target0.36 (24.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.06
BVpS-0.98
TBVpS-0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-82.82%
ROA(5y)-75.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 110.63%
Cap/Sales 91.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.92
Altman-Z -17.78
F-Score5
WACC2.63%
ROIC/WACCN/A
Cap/Depr(3y)46.99%
Cap/Depr(5y)33.81%
Cap/Sales(3y)42.11%
Cap/Sales(5y)27.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.9%
EPS Next Y40%
EPS Next 2Y20.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)141.86%
Revenue growth 3Y10.38%
Revenue growth 5Y26.64%
Sales Q2Q%485.38%
Revenue Next Year100%
Revenue Next 2Y63.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.94%
OCF growth 3YN/A
OCF growth 5YN/A